This article is included in these additional categories:

Delivery & Task Orders | Medical | Small Business | USA

US Military Receives More ARD Vaccines

For more on this and other stories, please consider purchasing a membership.
If you are already a subscriber, login to your account.
Oct 3/06: Small business qualifier Barr Laboratories Inc. in Pomona, NY recently received a $20.8 million increment as part of a $68.9 million cost-plus-fixed-fee contract for reinstatement of the adenovirus type 4 and 7 vaccine program. Work will be performed in Pomona, NY (30%), Silver Spring, MD (7.5%), Chicago, IL (32.5%), and Columbia, SC (30%), and is expected to be complete by Sept. 30, 2010. This was a sole source contract initiated on March 5, 2001 by the U.S. Army Medical Research Acquisition Activity at Fort Detrick, MD (DAMD17-01-C-0058). Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress. Type 4 and Type 7 vaccines are targeted at this specific problem.

One Source: Hundreds of programs; Thousands of links, photos, and analyses

DII brings a complete collection of articles with original reporting and research, and expert analyses of events to your desktop – no need for multiple modules, or complex subscriptions. All supporting documents, links, & appendices accompany each article.


  • Save time
  • Eliminate your blind spots
  • Get the big picture, quickly
  • Keep up with the important facts
  • Stay on top of your projects or your competitors


  • Coverage of procurement and doctrine issues
  • Timeline of past and future program events
  • Comprehensive links to other useful resources